SCHEMBL4149332

SCHEMBL4149332

Cc1c(C(C)N2CCOCC2)c(=O)c(O)c2n1CCN(Cc1ccc(F)cc1)C2=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.39
GRM2 Q14416 1/20 0.39
CYP2D6 P10635 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
TP53 P04637 2/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
RAB9A P51151 2/20 0.34
POLB P06746 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HSD17B10 Q99714 1/20 0.33
AKR1B1 P15121 1/20 0.33
NPC1 O15118 1/20 0.33
P2RX7 Q99572 3/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
RECQL P46063 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4157924 0.91 KCNH2 (0.40) KCNH2GRM2CYP2D6HRH3TP53
SCHEMBL4148650 0.80 TP53 (0.37) KCNH2GRM2CYP2D6HRH3TP53
SCHEMBL4144158 0.78 GRM2 (0.50) KCNH2GRM2CYP2D6HRH3TP53
SCHEMBL16185300 0.73 TP53 (0.39) KCNH2GRM2CYP2D6HRH3TP53
SCHEMBL17547427 0.72 TP53 (0.41) KCNH2GRM2CYP2D6HRH3TP53
SCHEMBL3902833 0.72 GRM2 (0.47) KCNH2GRM2CYP2D6HRH3TP53
SCHEMBL4140673 0.71 GAA (0.44) KCNH2GRM2MEN1KMT2ARAB9A
SCHEMBL4148598 0.71 TP53 (0.41) KCNH2GRM2TP53MEN1KMT2A
SCHEMBL16185333 0.71 AKR1B1 (0.39) KCNH2GRM2TP53MEN1KMT2A
SCHEMBL2895560 0.71 MEN1 (0.47) KCNH2GRM2CYP2D6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070161639-A1 Hiv integrase inhibitors ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-07-12 US claimed
EP-1725554-A1 HIV INTEGRASE INHIBITORS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2006-11-29 EP claimed
WO-2005087766-A1 HIV INTEGRASE INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2005-09-22 WO claimed
US-20090099168-A1 HIV Integrase inhibitors DONGHI MONICA 2009-04-16 US disclosed
US-20090099168-A1 HIV Integrase inhibitors DONGHI MONICA 2009-04-16 US disclosed
US-20090099168-A1 HIV Integrase inhibitors DONGHI MONICA 2009-04-16 US disclosed
US-20070161639-A1 Hiv integrase inhibitors ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-07-12 US disclosed
US-20070161639-A1 Hiv integrase inhibitors ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-07-12 US disclosed
US-20070161639-A1 Hiv integrase inhibitors ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161639-A1 Hiv integrase inhibitors DPYD, DUT, TYMP KCNH2 666/4885GRM2 3168/4885CYP2D6 296/4885
US-20090099168-A1 HIV Integrase inhibitors DPYD, DUT, QDPR KCNH2 722/4885GRM2 3764/4885CYP2D6 341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.